- Registrational expansion cohort enrolled 71 participants; topline data planned for Q1 2027 - WALTHAM, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted ...
Musculoskeletal anomalies are present in up to 50% of patients with prune belly syndrome (also known as Eagle-Barrett syndrome), requiring extensive orthopaedic management. However, to date, no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results